National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Belatacept, in combination with corticosteroids and a mycophenolic acid (MPA), is indicated for prophylaxis of graft rejection in adults receiving a renal transplant. It is recommended to add an interleukin (IL)-2 receptor antagonist for induction therapy to this belatacept-based regimen.

Rapid Review

Commenced Completed Outcome
15/11/2011 23/01/2012 Full Pharmacoeconomic Evaluation Recommended